IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1

CUSIP: 46333XAD0

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Debt / DBCV 2.250% 6/1
Market price (% of par)
118.01%
Total 13F principal
$333,479,002
Principal change
-$3,314,998
Total reported market value
$393,694,562
Number of holders
34
Value change
-$3,090,166
Number of buys
14
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 46333XAD0?
CUSIP 46333XAD0 identifies 46333XAD0 - IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1 as of Q1 2018

As of 31 Mar 2018, IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1 was held by 34 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $333,479,002 in principal (par value) of the bond. The largest 10 bondholders included Linden Advisors LP, WOLVERINE ASSET MANAGEMENT LLC, CITADEL ADVISORS LLC, UBS ASSET MANAGEMENT AMERICAS INC, CALAMOS ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, Polar Asset Management Partners Inc., CAPSTONE INVESTMENT ADVISORS, LLC, Davidson Kempner Capital Management LP, and HBK INVESTMENTS L P. This page lists 34 institutional bondholders reporting positions for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.